ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ME Therapeutics Holdings Inc., a biotech firm specializing in Immuno-Oncology, has announced a non-brokered private placement aimed at raising $1.55 million. The funds are planned to support the company’s research and development, regulatory processes, and general operating needs. The private placement comprises units priced at $1.00, with each unit including a share and a warrant, potentially accelerating if certain trading conditions are met.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.